These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 31770532)

  • 1. The frequency of CpG and non-CpG methylation of Notch3 gene promoter determines its expression levels in breast cancer cells.
    Xiao W; Liu X; Niu X; Li C; Guo Y; Tan J; Xiong W; Fan L; Li Y
    Exp Cell Res; 2020 Jan; 386(2):111743. PubMed ID: 31770532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The EZH2- H3K27me3-DNMT1 complex orchestrates epigenetic silencing of the wwc1 gene, a Hippo/YAP pathway upstream effector, in breast cancer epithelial cells.
    Liu X; Li C; Zhang R; Xiao W; Niu X; Ye X; Li Z; Guo Y; Tan J; Li Y
    Cell Signal; 2018 Nov; 51():243-256. PubMed ID: 30121333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methyltransferase 3-like affects promoter methylation of thymine DNA glycosylase independently of DNMT1 and DNMT3B in cancer cells.
    Kim H; Park J; Jung Y; Song SH; Han SW; Oh DY; Im SA; Bang YJ; Kim TY
    Int J Oncol; 2010 Jun; 36(6):1563-72. PubMed ID: 20428781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting DNA methylation for treating triple-negative breast cancer.
    Yu J; Zayas J; Qin B; Wang L
    Pharmacogenomics; 2019 Nov; 20(16):1151-1157. PubMed ID: 31755366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased expression of EZH2 reactivates RASSF2A by reversal of promoter methylation in breast cancer cells.
    Yu P; Guo Y; Yusufu M; Liu Z; Wang S; Yin X; Peng G; Wang L; Zhao X; Guo H; Huang T; Liu C
    Cell Biol Int; 2016 Oct; 40(10):1062-70. PubMed ID: 27436059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of DNMT1 and ERRα crosstalk suppresses breast cancer via derepression of IRF4.
    Vernier M; McGuirk S; Dufour CR; Wan L; Audet-Walsh E; St-Pierre J; Giguère V
    Oncogene; 2020 Oct; 39(41):6406-6420. PubMed ID: 32855526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutant p53 binds to estrogen receptor negative promoter via DNMT1 and HDAC1 in MDA-MB-468 breast cancer cells.
    Arabsolghar R; Azimi T; Rasti M
    Mol Biol Rep; 2013 Mar; 40(3):2617-25. PubMed ID: 23242655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NOTCH3 expression is linked to breast cancer seeding and distant metastasis.
    Leontovich AA; Jalalirad M; Salisbury JL; Mills L; Haddox C; Schroeder M; Tuma A; Guicciardi ME; Zammataro L; Gambino MW; Amato A; Di Leonardo A; McCubrey J; Lange CA; Liu M; Haddad T; Goetz M; Boughey J; Sarkaria J; Wang L; Ingle JN; Galanis E; D'Assoro AB
    Breast Cancer Res; 2018 Sep; 20(1):105. PubMed ID: 30180881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines.
    Roll JD; Rivenbark AG; Jones WD; Coleman WB
    Mol Cancer; 2008 Jan; 7():15. PubMed ID: 18221536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The carcinogen cadmium elevates CpG-demethylation and enrichment of NFYA and E2F1 in the promoter of oncogenic PRMT5 and EZH2 methyltransferases resulting in their elevated expression in vitro.
    Ghosh K; Chatterjee B; Behera P; Kanade SR
    Chemosphere; 2020 Mar; 242():125186. PubMed ID: 31675590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MYC and DNMT3A-mediated DNA methylation represses microRNA-200b in triple negative breast cancer.
    Pang Y; Liu J; Li X; Xiao G; Wang H; Yang G; Li Y; Tang SC; Qin S; Du N; Zhang H; Liu D; Sun X; Ren H
    J Cell Mol Med; 2018 Dec; 22(12):6262-6274. PubMed ID: 30324719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 Binds to estrogen receptor 1 promoter in human breast cancer cells.
    Rasti M; Arabsolghar R; Khatooni Z; Mostafavi-Pour Z
    Pathol Oncol Res; 2012 Apr; 18(2):169-75. PubMed ID: 21655924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific inhibition of DNMT1 by antisense oligonucleotides induces re-expression of estrogen receptor-alpha (ER) in ER-negative human breast cancer cell lines.
    Yan L; Nass SJ; Smith D; Nelson WG; Herman JG; Davidson NE
    Cancer Biol Ther; 2003; 2(5):552-6. PubMed ID: 14614325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methyltransferase expression and tumor suppressor gene methylation in sporadic and familial colorectal cancer.
    Joensuu EI; Nieminen TT; Lotsari JE; Pavicic W; Abdel-Rahman WM; Peltomäki P
    Genes Chromosomes Cancer; 2015 Dec; 54(12):776-87. PubMed ID: 26305882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic screen of human DNA repair genes identifies aberrant promoter methylation of NEIL1 in head and neck squamous cell carcinoma.
    Chaisaingmongkol J; Popanda O; Warta R; Dyckhoff G; Herpel E; Geiselhart L; Claus R; Lasitschka F; Campos B; Oakes CC; Bermejo JL; Herold-Mende C; Plass C; Schmezer P
    Oncogene; 2012 Dec; 31(49):5108-16. PubMed ID: 22286769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interaction between miR-21 and DNA methylation in different breast cancer cells].
    Zhang YY; Tian WP; Mei M
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2015 May; 31(3):220-4. PubMed ID: 26387181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PRMT5 functionally associates with EZH2 to promote colorectal cancer progression through epigenetically repressing CDKN2B expression.
    Yang L; Ma DW; Cao YP; Li DZ; Zhou X; Feng JF; Bao J
    Theranostics; 2021; 11(8):3742-3759. PubMed ID: 33664859
    [No Abstract]   [Full Text] [Related]  

  • 18. The possible role of EZH2 and DNMT1 polymorphisms in sporadic triple-negative breast carcinoma in southern Chinese females.
    Tao R; Chen Z; Wu P; Liu C; Peng Y; Zhao W; Hu C; Feng J
    Tumour Biol; 2015 Dec; 36(12):9849-55. PubMed ID: 26162541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant promoter methylation of the ABCG2 gene in renal carcinoma.
    To KK; Zhan Z; Bates SE
    Mol Cell Biol; 2006 Nov; 26(22):8572-85. PubMed ID: 16954373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.